Download STATUS DECISION OF CONTROLLED AND NON

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Drug design wikipedia , lookup

Psychedelic therapy wikipedia , lookup

Neuropharmacology wikipedia , lookup

Prescription costs wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Medication wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Environmental persistent pharmaceutical pollutant wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Drug discovery wikipedia , lookup

Drug interaction wikipedia , lookup

Pharmacognosy wikipedia , lookup

Psychopharmacology wikipedia , lookup

Polysubstance dependence wikipedia , lookup

Transcript
Health
Canada
Santé
Canada
STATUS DECISION OF CONTROLLED
AND NON-CONTROLLED SUBSTANCE(S)
Substance:
Prostanozol
Based on the current information available to the Office of Controlled Substances, it appears that
the above substance is:
Controlled
Not Controlled
9
T
under the schedules of the Controlled Drugs and Substances Act (CDSA) for the following
reason(s):
•
The substance is a steroid marketed as a nutritional supplement for body building
purposes but has not been shown in the scientific literature to display anabolic
activity, and therefore it is not included under item 23 of Schedule IV to the
CDSA.
Prepared by:
Date: April 18th 2011
Evelyn Soo
Verified by:
Date:
Kim Barber
Approved by:
Date:
DIRECTOR, OFFICE OF CONTROLLED SUBSTANCES
This status was requested by: Member of public
Drug Status Report
Drug: Prostanozol
Drug Name Status: Prostanozol is the common name.
Chemical Name:
(5alpha,17beta)-17-((tetrahydro-2H-pyran-2-yl)oxy)-2'H-Androst-2-eno(3,2-c)pyrazole
Other Names: [3,2-c]Pyrazole-5alpha-androstano-17beta-tetrahydropyranol ether; [3,2c]pyrazole-etioallocholan-17beta-tetrahydropyranol ether
Chemical structure:
Molecular Formula: C25H 38N2O2
Pharmacological class / Application: steroid
CAS-RN: 1186001-41-1
International status:
US: Prostanozol is not currently listed in the CSA. However, according to the DEA website, the
substance is a new designer steroid that is believed to be a more potent than testosterone, and is
currently under review for inclusion under schedule III to the CSA1.
United Nations: The substance is not listed on the Yellow List - List of Narcotic Drugs under
International Control nor the Green List - List of Psychotropic Substances under International
Control.
Canadian Status: Prostanozol is not currently listed in the CDSA. The substance has been
reported to be an ingredient in an nutritional supplement known as Win 50 and which marketed
by Double Dragon pharmaceuticals2. “Anabolic steroids and their derivatives” are currently
controlled under item 23 of Schedule IV to the CDSA. While there are reports that prostanozol
1
http://www.justice.gov/dea/pubs/cngrtest/ct092909.pdf
2
http://win50doubledragon.blogspot.com/
3
is an anabolic steroid or a prohormone3, there is no evidence in the scientific literature to show
that the substance displays anabolic activity. Therefore, until there is available unequivocal
evidence to show that prostanozol produces anabolic effects, the substance it cannot be included
under item 23 of Schedule IV to the CDSA.
Recommendation: Prostanozol is not currently included under item 23 of Schedule IV to the
CDSA is not a controlled substance.
Date: 18 April 2011
3
Geyer, H. et al. (2008)Nutritional supplements cross-contaminated and faked with doping substances, J.
Mass Spectrometr. 43:892-902.